Lista de obras - Alfredo Rodríguez-Antigüedad

A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.

artículo científico publicado en 2015

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients

artículo científico publicado en 2016

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

artículo científico publicado en 2014

Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis

artículo científico publicado en 2008

Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology.

artículo científico publicado en 2014

Biomarkers in multiple sclerosis

artículo científico publicado en 2013

Biomarkers in multiple sclerosis: an update for 2014

artículo científico publicado en 2014

Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

artículo científico publicado en 2015

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

artículo científico publicado en 2011

Closing the case ofAPOEin multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1

Excitotoxic damage to white matter.

artículo científico publicado en 2007

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease

artículo científico publicado en 2019

FTY720 attenuates excitotoxicity and neuroinflammation.

artículo científico publicado en 2015

Fine mapping and functional analysis of the multiple sclerosis risk gene CD6

artículo científico publicado en 2013

Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

artículo científico publicado en 2011

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk

artículo científico publicado en 2013

Genome-wide significant association with seven novel multiple sclerosis risk loci

artículo científico publicado en 2015

Hematocrit and clinical outcome in acute cerebral infarction.

artículo científico publicado en 1987

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

artículo científico publicado en 2014

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

artículo científico publicado en 2012

Increased expression of cystine/glutamate antiporter in multiple sclerosis ⬇️

artículo científico publicado el 3 de junio de 2011

Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial.

artículo científico publicado en 2016

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

artículo científico publicado en 2013

Multiple sclerosis: Pregnancy and women's health issues.

artículo científico publicado en 2016

Neurophysiology training in the Neurology Specialist Education Program in Spain

scientific article published on 20 February 2011

P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

artículo científico publicado en 2007

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

artículo científico publicado en 2015

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes

article

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).

artículo científico publicado en 2015

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)

artículo científico publicado en 2015

Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting

artículo científico publicado en 2016

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I).

artículo científico publicado en 2017

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).

artículo científico publicado en 2017

Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

artículo científico publicado en 2011

Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

artículo científico publicado en 2011

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

artículo científico

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

artículo científico publicado el 16 de junio de 2012

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

artículo científico publicado en 2013

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

artículo científico publicado en 2013

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

artículo científico

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

artículo científico

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

artículo científico publicado en 2014

Spanish consensus on the use of natalizumab (Tysabri®)-2013.

artículo científico publicado en 2013

TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.

artículo científico publicado en 2013

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain

scientific article published on 09 December 2009

The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis

artículo científico publicado en 2016

Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

artículo científico publicado en 2011

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

artículo científico publicado en 2010

[Botulinum toxin A in chronic refractory migraine: premarketing experience]

article by Luis C Álvaro-González et al published 1 October 2012 in Revista de neurología

[Specific neurology emergency training of medical residents in Spain]

artículo científico publicado en 2010

Documento del Grupo de Consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple ⬇️

artículo científico publicado el 3 de mayo de 2013

Lista de obras de Alfredo Rodríguez-Antigüedad

A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis

Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology.

Biomarkers in multiple sclerosis

Biomarkers in multiple sclerosis: an update for 2014

Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

Closing the case ofAPOEin multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1

Excitotoxic damage to white matter.

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease

FTY720 attenuates excitotoxicity and neuroinflammation.

Fine mapping and functional analysis of the multiple sclerosis risk gene CD6

Gain-of-function of P2X7 receptor gene variants in multiple sclerosis

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk

Genome-wide significant association with seven novel multiple sclerosis risk loci

Hematocrit and clinical outcome in acute cerebral infarction.

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

Increased expression of cystine/glutamate antiporter in multiple sclerosis ⬇️

Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial.

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

Multiple sclerosis: Pregnancy and women's health issues.

Neurophysiology training in the Neurology Specialist Education Program in Spain

P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)

Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I).

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).

Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Spanish consensus on the use of natalizumab (Tysabri®)-2013.

TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain

The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis

Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

[Botulinum toxin A in chronic refractory migraine: premarketing experience]

[Specific neurology emergency training of medical residents in Spain]

Documento del Grupo de Consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple ⬇️